At a glance
- Originator Pfizer
- Class
- Mechanism of Action Glucocorticoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 17 Dec 2003 No development reported - Preclinical for Obesity in USA (unspecified route)
- 20 Sep 2001 New profile
- 19 Sep 2001 Preclinical development for Obesity in USA (Unknown route)